In vitro anti-human immunodeficiency virus (HIV) activity of the chromanone derivative, 12-oxocalanolide A, a novel NNRTI

Bioorganic and Medicinal Chemistry Letters

Volumn 8, Issue 16, 1998, Pages 2179-2184

  Xu, Ze Qi ^b   Buckheit Jr , Robert W ^a   Stup, Tracy L ^a   Flavin, Michael T ^b   Khilevich, Albert ^b   Rizzo, John D ^b   Lin, Lin ^b   Zembower, David E ^b  

^a SOUTHERN RESEARCH INSTITUTE   (United States)

^b MediChem Research Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

12 OXOCALANOLIDE A; 4 CHROMANONE DERIVATIVE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CALANOLIDE A; RNA DIRECTED DNA POLYMERASE INHIBITOR; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; SIMIAN IMMUNODEFICIENCY VIRUS; STRUCTURE ACTIVITY RELATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; CELL LINE; CHROMONES; COUMARINS; DRUG DESIGN; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; LEUKOCYTES; MACROPHAGES; MONOCYTES; PYRANOCOUMARINS; REVERSE TRANSCRIPTASE INHIBITORS; SIMIAN IMMUNODEFICIENCY VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 0032544154     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(98)00380-1     Document Type: Article

References (18)

1. 1. Kashman, Y.; Gustafson, K. R.; Fuller, R. W.; Cardellina, J. H., II; McMahon, J. B.; Currens, M. J.; Buckheit, R. W.; Hughes, S. H.; Cragg, G. M.; Boyd, M. R. J. Med. Chem. 1992, 35, 2735.
2. 2. Patil, A. D.; Freyer, A. J.; Eggleston, D. S.; Haltiwanger, R. C.; Bean, M. F.; Taylor, P. B.; Caranfa, M. J.; Breen, A. L.; Bartus, H. R.; Johnson, R. K.; Hertzberg, R. P.; Westley, J. W. J. Med. Chem. 1993, 36, 4131.
3. 3. Flavin, M. T.; Rizzo, J. D.; Khilevich, A.; Kucherenko, A.; Sheinkman, A. K.; Vilaychack, V.; Lin, L.; Chen, W.; Greenwood, E. M.; Pengsuparp, T.; Pezzuto, J. M.; Hughes, S. H.; Flavin, T. M.; Cibulski, M.; Boulanger, W. A.; Shone, R. L.; Xu, Z.-Q. J. Med. Chem. 1996, 39, 1303.
4. 4. Currens, M. J.; Gulakowski, R. J.; Mariner, J. M.; Moran, R. A.; Buckheit, R. W., Jr.; Gustafson, K. R.; McMahon, J. B.; Boyd, M. R. J. Pharmacol. Exp. Ther. 1996, 279, 645.
5. 5. Boyer, P. L.; Currens, M. J.; McMahon, J. B.; Boyd, M. R.; Hughes, S. H. J. Virol. 1993, 67, 2412.
6. 6. Hizi, A.; Tal, R.; Shaharabany, M.; Currens, M. J.; Boyd, M. R.; Hughes, S. H.; McMahon, J. B. Antimicrob. Agents Chemother. 1993, 37, 1037.
7. 7. Buckheit, R. W., Jr.; Fliakas-Boltz, V.; Decker, W. D.; Roberson, J. L.; Stup, T. L.; Pyle, C. A.; White, E. L.; McMahon, J. B.; Currens, M. J.; Boyd, M. R.; Bader, J. P. Antiviral Res. 1995, 26, 117.
8. 8. Buckheit, R. W., Jr.; Fliakas-Boltz, V.; Decker, W. D.; Roberson, J. L.; Pyle, C. A.; White, E. L.; Bowdon, B. J.; McMahon, J. B.; Boyd, M. R.; Bader, J. P.; Nickell, D. G.; Barth, H.; Antonucci, T.K. Antiviral Res. 1994, 25, 43.
9. 9. Buckheit, R. W., Jr.; Fliakas-Boltz, V.; Yeagy-Bargo, S.; Weislow, O.; Mayers, D. L.; Boyer, P. L.; Hughes, S. H.; Pan, B.-C.; Chu, S.-H.; Bader, J. P. Virology 1995, 210, 186.
10. 10. Buckheit, R. W., Jr.; Kilnjerski, T. L.; Fliakas-Boltz, V.; Russell, J. D.; Stup, T. L.; Palansch, L. A.; Brouwer, W. G.; Dao, D. C.; Harrison, W. A.; Schultz, R. J.; Bader, J. P.; Yang, S. S. Antimicrob. Agents Chemother. 1995, 39, 2718.
11. 11. Currens, M. J.; Mariner, J. M.; McMahon, J. B.; Boyd, M. R. J. Pharmacol. Exp. Ther. 1996, 279, 652.
12. 12. Creagh, T.; Xu, Z.-Q.; Ray, L.; Giltner, J.; Nayer, T.; Ruckle, J. 5th Conference on Retroviruses and Opportunistic Infections, Chicago, February 1-5, 1998, Abstract 652.
13. 13. Zembower, D. E.; Liao, S.; Flavin, M. T.; Xu, Z.-Q.; Stup, T. L.; Buckheit, R. W., Jr.; Khilevich, A.; Mar, A. A.; Sheinkman; A. K . J. Med. Chem. 1997, 40, 1005.
14. 14. Galinis, D. L.; Fuller, R. W.; McKee, T. C.; Cardellina, J. H., II; Gulakowski, R. J.; McMahon, J. B.; Boyd, M. R. J. Med. Chem. 1996, 39, 4507.
15. 15. Parts of these results were presented previously: Xu, Z.-Q.; Flavin, M. T.; Buckheit, R. W., Jr.; Khilevich, A.; Zembower, D. E.; Roca-Actin, J. 10th International Conference on Antiviral Research, Atlanta, Georgia, April 6-11, 1997, Abstract 47.
16. 16. Khilevich, A.; Rizzo, J. D.; Flavin, M. T.; Sheinkman; A. K.; Mar, A.; Kucherenko, A.; Yan, C.; Dzekhtser, S.; Brankovic, D.; Lin, L.; Liu, J.; Rizzo, T. M.; Xu, Z.-Q. Synthetic Commun. 1996, 20, 3757.
17. 17. Khilevich, A.; Mar, A.; Flavin, M. T.; Rizzo, J. D.; Dzekhtser, S.; Brankovic, D.; Lin, L.; Zhang, H.; Chen, W.; Liao, S.; Zembower, D. E.; Xu, Z.-Q. Tetrahedron: Asymmetry 1996, 7, 3315.
18. 18. Debyser, Z.; De Vreese, K.; Pauwels, R.; Yamamoto, N.; Anne, J.; De Clercq, E.; Desmyter, J. J. Gen. Virol. 1992, 73, 1799.